INTRODUCTION
============

Crawford (1964) \[[@b1-aps-2018-00990]\] first introduced the scalp as an unusual skin donor site in the treatment of extensive deep burns in children. The scalp, although it is hairy, is a highly favorable donor site for obtaining thin skin grafts for burn patients \[[@b2-aps-2018-00990]-[@b5-aps-2018-00990]\]. Scalp donor sites heal rapidly because they are rich in hair follicle structures, which contain abundant regenerative epithelial cells and dermis cells. Another major advantage of the scalp as a donor site is that scarring is not visible. However, the surface of the scalp makes up a limited proportion of the entire body surface.

To overcome the disadvantage of the relatively small area of the scalp as donor, Zakine et al. \[[@b6-aps-2018-00990]\] reported harvesting two layers of a 0.2-mm graft, a dermoepidermal graft and a dermal graft, from the scalp during a single procedure in 15 burn patients. Scalp dermal grafts contain abundant epithelial and regenerative dermal cells, which facilitate complete healing of the recipient site. Dermal autografts from the scalp have been mainly used in burned wounds, although they can also be used in various other types of wounds. However, there are no reports that used scalp split-thickness skin graft (SSG) and split-thickness dermal graft (SDG) for postburn scar contractures (PBSCs) and postburn scar deformities (PBSDs) of the face or lower extremities.

This study aimed to double the scalp donor surface by harvesting a thin SDG immediately after a thin SSG. We also verified the quality of recipient site healing after receiving a SSG and a SDG and scalp healing after double graft harvesting in burn and reconstructive patients.

METHODS
=======

Fourteen Korean patients hospitalized in our burn and reconstructive unit were included in this retrospective study between August 2013 and July 2017. Data on factors including sex, age, reason for surgery, recipient site, graft thickness, and area of each scalp SSG and SDG at the time of surgery were collected from the medical records of the included patients. The postoperative variables included the healing time of the donor site, epithelialization time of the scalp SDG, and incidence of complications. After follow-up for 1 year, the incidence of late complications and the Vancouver Scar Scale scores of the grafts were reviewed.

Surgical technique
------------------

The recipient sites for grafting were prepared by debriding burn wounds and flap donor wounds, shaving the scars of dyspigmented and uneven PBSDs, and releasing PBSCs covered with artificial dermal matrix (ADM).

The scalp was shaved and sterilized with a povidone solution containing 70% alcohol. Then, 1:300,000 adrenaline mixed with sterile physiologic saline (NaCl 0.9%) was infiltrated into the subgaleal space to create a cushion in order to harvest a broad region of skin. The dual scalp SSG and SDG were then harvested with a Zimmer Air Dermatome (Zimmer Inc., Warsaw, IN, USA). Hemostasis was achieved by using a temporary gauze dressing soaked in adrenaline solution containing 10 mg adrenaline in 1 L NaCl 0.9%. After hemostasis, a Mepitel sheet (Mölnlycke Health Care, Gothenburg, Sweden) was tightly fixed with staples to the donor site, covered with absorbent gauze and secured with an elastic bandage and an elastic stocking.

Exudates were absorbed by the gauze on the Mepitel sheet, which was changed at the scalp donor site between 3 and 5 days after surgery. After this period, the epithelialization of scalp wounds was observed beneath the Mepitel sheet after partially removing the staples ([Fig. 1](#f1-aps-2018-00990){ref-type="fig"}). The upper bandages, absorbent gauze and Mepitel sheet can be removed from the donor site when the site is fully epithelized.

After grafting, graft maturation of the scalp SSG and SDG recipient areas was managed for up to one year with moisturizing cream, silicone gel or pad and pressure garments (20--25 mmHg pressure).

Assessment
----------

The scalp skin thickness was measured preoperatively by ultrasonography (Esaote MyLab One, Genoa, Italy) ([Fig. 2](#f2-aps-2018-00990){ref-type="fig"}). Ultrasonography measured the skin thickness after shaving the hair on the temporal, vertex, parieto-temporal and occipital areas in patients requiring large-sized skin grafts, and on the temporo-occipital area in patients requiring small-sized skin grafts. We confirmed the histology of the scalp SSG and SDGs ([Fig. 3](#f3-aps-2018-00990){ref-type="fig"}). Scalp donor healing was assessed by histological findings of punch biopsy ([Fig. 4](#f4-aps-2018-00990){ref-type="fig"}). Donor site healing was defined as greater than 95% epithelialization of the donor site.

Postoperative variables were healing time of the donor site, epithelialization time of scalp SDG and incidence of complications. After follow-up for one year, the incidence of late complications and the Vancouver scar scale scores of the grafts were reviewed.

RESULTS
=======

Fourteen patients, six men and eight women with a mean age of 34.2 years (range, 5--56 years), were treated according to our protocol. The reasons for recipient site grafting were PBSCs (6 patients), PBSDs (4 patients), flame burns (2 patients), flap donor site (1 patient), and friction wound (1 patient) ([Table 1](#t1-aps-2018-00990){ref-type="table"}).

The recipient sites of scalp SSGs were the face (n=5), lower extremity (n=5), body (n=2) and upper extremity (n=2), and the recipient sites of scalp SDGs were the face (n=6), lower extremity (n=6), upper extremity (n=2) and body (n=2) ([Figs. 5](#f5-aps-2018-00990){ref-type="fig"}-[](#f6-aps-2018-00990){ref-type="fig"}[7](#f7-aps-2018-00990){ref-type="fig"}).

The mean thickness of scalp SSGs was 0.0089 inches (range, 0.008--0.012 inches). The mean area of scalp SSGs was 151.8 cm^2^ (range, 2--266 cm^2^). The mean thickness of scalp SDGs was 0.0089 inches (range, 0.008--0.010 inches). The mean area of scalp SDGs was 88.2 cm^2^ (range, 10--200 cm^2^). The mean epithelialization time of scalp SDGs was 10 days (range, 7--14 days). The mean thickness of scalp donor defects was 0.018 inches (range, 0.016--0.022 inches). The mean healing time of scalp donors was 9.9 days (range, 7--14 days).

Partial loss of scalp SSGs occurred in two cases. Partial loss of scalp SDGs occurred in five cases. The recipient's grafts were lost due to infection by multidrug-resistant *Acinetobacter baumannii* in two cases and methicillin-resistant *Staphylococcus aureus* (MRSA) in one case. The donor sites of the secondary SSGs for graft loss were the thigh (n=2) and the scalp (n=1). Tufted scar deformity (2×5 cm in size) of the scalp donor site due to MRSA was treated with scar revision.

The Vancouver scar scale scores were similar for each graft after a 1-year follow-up of scalp SSGs (mean score of 2.4) and scalp SDGs (mean score of 1.8) in 11 patients. However, the scalp SDGs showed more hypochromic regions than the scalp SSGs.

DISCUSSION
==========

Previous reports have described thick scalp microdermis grafts for thigh burns \[[@b7-aps-2018-00990]\] and hair-bearing dermal micrografts for hiding cleft lip scars \[[@b8-aps-2018-00990]\]. The double SSG and SDG were compared experimentally for their ability to resurface full thickness skin defects in a pig model \[[@b9-aps-2018-00990]\]. Zakine et al. \[[@b6-aps-2018-00990]\] reported fifteen burn patients treated with two layers of 0.2 mm SSG, a dermoepidermal graft and a dermal graft, harvested from hairy scalp. Dermal autografts from the scalp have been mainly used in burned wounds, although they can also be used in various other types of wounds. However, the author mainly used scalp SSGs and SDGs for PBSCs and PBSDs of the face or lower extremities. In addition, the mean thickness of scalp SSGs and SDGs was 0.0089 inches (0.23 mm), and the mean thickness of scalp donor defects was 0.018 inches (0.46 mm). The mean healing time of the scalp donor site was 9.9 days, similar to that in a previous report of 9.8 days \[[@b6-aps-2018-00990]\].

In wound beds after SSG harvesting, regenerative healing without complications can be induced by maintaining the appropriate thickness of the reticular dermis without damaging the hair follicle. Although stem cells of the hair follicle bulge do not normally contribute to epidermis cells, if the epidermis is damaged, cells from the bulge are recruited into the epidermis and move linearly toward the center of the wound. Bulge-derived cells have epidermal phenotypes but are stem cells involved in acute wound healing, most of which are transiently amplified cells and removed within several weeks \[[@b10-aps-2018-00990],[@b11-aps-2018-00990]\].

Dermal fibroblasts in scalp skin arise from the neural crest in embryonic origin. They undergo differentiation and lineage commitments to give arise to both upper and lower lineages. Dermal papilla, arrector pili muscle, dermal sheath and papillary dermis are derived from the upper lineage \[[@b12-aps-2018-00990]\]. Fibroblasts of dermal papilla, dermal sheath of hair follicle are multipotent stem cells \[[@b13-aps-2018-00990]\]. Epidermal β-catenin activation stimulates the expansion of the upper dermal lineage in rendering wounds permissive for hair follicle formation \[[@b14-aps-2018-00990]\]. Therefore, the author suggests that scalp donor wounds can be healed early without scar formation by interfollicular regeneration of the dermis and by epidermis stem cells from hair follicles in the wound bed. Additionally, interfollicular regenerative healing from hair follicles occurred within 2 weeks regardless of the depth of the skin defect.

The scalp dermal grafts do not need to be covered with epidermal grafts, and they become re-epithelialized in the epithelial cells of the follicular wall and abundant adnexa approximately 10 days after grafting. Meshed SDG could be used for easy graft uptake \[[@b15-aps-2018-00990],[@b16-aps-2018-00990]\]. However, unmeshed SDG was used in all cases in this study. The time to epithelialization of dermal grafts harvested from skin from other body regions (9--28 days) \[[@b15-aps-2018-00990]-[@b18-aps-2018-00990]\] was longer than that of the scalp dermal grafts in this study. Fewer follicular adnexal epithelial cells are contained in dermal grafts of skin from other body regions than in scalp dermal grafts. Thus, epithelialization time seems to be affected by the size of the epithelialized dermal graft from the epidermis around the dermal graft.

The temporo-occipital area can be easily exposed under general anesthesia and can cover the surgical site with partial hair shaving. The thickest region of scalp skin in individuals was the vertex area. The next thickest region was the occipital area. The thinnest region was the parieto-temporal area. The skin thickness of the scalp donor site was measured by preoperative ultrasonography ([Fig. 2](#f2-aps-2018-00990){ref-type="fig"}). The adjusted thickness of the dermatome in harvested skin grafts varies depending on the operator's harvesting techniques and tumescent skin expansion. Therefore, a histological evaluation of the obtained skin thickness is required ([Fig. 3](#f3-aps-2018-00990){ref-type="fig"}). The maximum thickness adjustment of the Zimmer dermatome for harvesting skin is 30 (0.03 inches, 0.76 mm). The skin thickness is 0.05 mm for the epidermis and 0.1 mm for the epidermal rete ridge \[[@b6-aps-2018-00990]\]. The SSG type is determined by adjusting the dermatome to an appropriate thickness according to the thickness of the donor skin. SSGs of 0.4 to \<0.8 mm in thickness are considered intermediate SSGs when obtained from adult thigh donor regions of 1.6 mm in thickness but are considered thin SSGs when obtained from adult scalp donor regions of 2.4 mm in thickness ([Table 2](#t2-aps-2018-00990){ref-type="table"}). The thickness of the harvested SSG and SDG is usually indicated by the setting of the dermatome rather than the actual measurement of the graft. In practice, we have found that the thickness of grafts may vary for the same dermatome setting. These variations are affected by the pressure exerted on the dermatome, the angle of the dermatome, the amount of the tumescent injection, and the harvest site of the scalp.

The scalp donor sites exhibited early folliculitis and scab formation, and conservative treatment was possible except for in one case of tufted scar deformity, which was treated with scar revision. No alopecia was observed on the scalp donor site. The main treatment for folliculitis and scab formation is conservative, followed by rinsing the scalp with povidone solution and topical antiseptic ointment. This process is repeated daily until folliculitis or scab formation is withdrawn.

During the epithelialization period, scalp dermal grafts can become contaminated by resistant bacteria, causing graft failure. Graft failure occurred at three sites of two patients due to MRAB and MRSA in the scalp SSGs and SDGs, and regrafting was required. ADM grafts were resistant to infection despite graft loss at that time. The maturation period of combined ADM and SSGs or SDGs is longer than the maturation period of SSGs or SDGs alone. In conclusion, using the scalp as a donor for double-harvested skin grafts can overcome the disadvantages relating to the relatively small area of the scalp. In addition, deeper wounds of the scalp donor site than previously reported acheived scar-free healing.
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![Photographic findings of scalp donor healing\
(A) Whitish areas of epidermis regeneration around the hairs were observed at 3 days postoperatively. (B) Complete healing of the scalp donor wound was observed at 9 days postoperatively.](aps-2018-00990f1){#f1-aps-2018-00990}

![Preoperative ultrasonography\
The normal skin thickness of the scalp vertex area was 2.21 mm.](aps-2018-00990f2){#f2-aps-2018-00990}

![Histology of the scalp SSG and SDG\
Histological findings (H&E, ×100). (A) SSG with epidermis and papillary dermis. (B) SDG with reticular dermis, including adnexal structures rich in keratinocytes. SSG, split-thickness skin graft; SDG, split-thickness dermal graft.](aps-2018-00990f3){#f3-aps-2018-00990}

![Histological findings of the scalp donor site\
Histological findings of the scalp donor site at 9 days postoperatively. (A) Regenerated epithelium and regenerated dermal fibroblasts (H&E, ×40). (B) Regenerated dermal fibroblasts from the deep reticular border were stained dark blue according to the degree of differentiated collagen formation (Masson trichrome stain, ×40).](aps-2018-00990f4){#f4-aps-2018-00990}

![Scalp SSG and SDG in case 8\
Excision release of postburn scar contracture, Alloderm graft, and scalp split-thickness dermal graft (SDG) and split-thickness skin graft (SSG). (A) Preoperative postburn scar contracture around the left elbow. (B) An Alloderm graft covered the wound. (C) A scalp SDG was placed over the upper part of the Alloderm graft wound and a scalp SSG over the lower part. (D) Incomplete maturation of the grafts at 1 year and 8 months postoperatively.](aps-2018-00990f5){#f5-aps-2018-00990}

![Scalp SSG and SDG in case 7\
Debridement and scalp split-thickness skin graft (SSG) and split-thickness dermal graft (SDG) applied at the forehead. (A) Early findings of the scalp SSG and SDG at 5 days postoperatively. (B) Excellent outcomes of the grafts at 2 years postoperatively.](aps-2018-00990f6){#f6-aps-2018-00990}

![Scalp SSG and SDG in case 5\
Scar shaving and scalp split-thickness skin graft (SSG) and split-thickness dermal graft (SDG) applied at the left knee. (A) Immediate postoperative appearance. (B) Comparison of the colors of the grafts at 1 year postoperatively.](aps-2018-00990f7){#f7-aps-2018-00990}

###### 

Characteristics of patients

  Case no.   Sex   Age (yr)   Cause        ADM (size, cm^2^), at site            Recipient sites of scalp SSG   Thickness (inch)   Area of SSG (cm^2^)   Graft loss area (%)   Recipient sites of scalp SDG   Thickness (inch)   Area of SDG (cm^2^)   Time of epithelization of SDG (day)   Graft loss area (%)   Total donor defect (inch)   Donor site healing (day)   Donor site complications   Second operation   VSS score of SSG   VSS score of SDG
  ---------- ----- ---------- ------------ ------------------------------------- ------------------------------ ------------------ --------------------- --------------------- ------------------------------ ------------------ --------------------- ------------------------------------- --------------------- --------------------------- -------------------------- -------------------------- ------------------ ------------------ ------------------
  1          M     26         Flame                                              Forehead, cheek                0.01               160                   0                     Forehead, cheek                0.01               80                    11                                    5                     0.02                        11                         0                                             3                  2
  2          F     39         PBSC         Alloderm (354), flank and thigh       Flank                          0.008              266                   15, MRAB              Thigh                          0.008              88                    Re-graft                              90, MRAB              0.016                       8                          0                          Thigh SSG          3                  2
  3          F     31         PBSD                                               Forehead                       0.01               100                   0                     Nose, cheek                    0.01               100                   8                                     0                     0.02                        10                         0                                             3                  3
  4          M     51         Flap donor                                         Foot, leg                      0.012              87                    0                     Leg                            0.01               72                    Re-graft                              20, MRSA              0.022                       12                         0                          Thigh SSG          0                  0
  5          F     56         PBSD                                               Upper knee                     0.008              220                   0                     Lower knee                     0.01               200                   10                                    0                     0.018                       13                         0                                             2                  2
  6          M     32         PBSD                                               Nose, upper lip                0.008              50                    2                     Lower lip                      0.008              50                    14                                    0                     0.016                       11                         Tufted scar, MRSA          Scar revision      2                  1
  7          M     47         Flame                                              Forehead, chest                0.01               220                   0                     Cheek, chest                   0.01               160                   10                                    0                     0.02                        10                         0                                             3                  1
  8          F     40         PBSC         Alloderm (220), elbow and upper arm   Elbow                          0.009              180                   0                     Cheek, upper arm               0.009              140                   8                                     1                     0.018                       10                         0                                             3                  2
  9          F     8          PBSC         Megaderm (40), popliteal fossa        Popliteal fossa                0.008              190                   0                     Leg                            0.008              100                   14                                    0                     0.016                       8                          0                                             3                  2
  10         M     5          PBSC         Alloderm (70), popliteal fossa        Popliteal fossa, ankle         0.008              160                   0                     Leg                            0.008              50                    11                                    0                     0.016                       14                         0                                             3                  2
  11         M     30         Friction                                           Dorsal foot                    0.008              2                     0                     Dorsal foot                    0.01               10                    9                                     0                     0.018                       8                          0                                             None               None
  12         F     19         PBSD                                               Back                           0.009              250                   0                     Back                           0.008              50                    10                                    0                     0.017                       9                          0                                             0                  1
  13         F     45         PBSC         Prmatrix (110), neck                  Neck                           0.008              110                   0                     Both cheeks                    0.008              90                    7                                     0                     0.016                       7                          0                                             None               None
  14         F     50         PBSC         Megaderm (40), elbow                  Upper arm, forearm             0.008              130                   0                     Elbow                          0.008              45                    8                                     9                     0.016                       8                          0                          Scalp SSG          None               None

ADM, artificial dermal matrix; SSG, split-thickness skin graft; SDG, split-thickness dermal graft; VSS, Vancouver Scar Scale; M, male; F, female; PBSC, postburn scar contracture; MRAB, multidrug-resistant *Acinetobacter baumannii*; PBSD, postburn scar deformity; MRSA, methicillin-resistant *Staphylococcus aureus*.

###### 

Comparison of SSG thickness depending on whether the donor skin is from the thigh or scalp

  Type of SSG        Ratio of total skin thickness (%)   Thigh skin thickness   Scalp skin thickness                    
  ------------------ ----------------------------------- ---------------------- ---------------------- ---------------- --------------------
  Epidermal SSG                                          0.1                    0.004                  0.1              0.004
  Thin SSG           \< 25 (1/4)                         \< 0.4                 \< 0.016               \< 0.6           \< 0.024
  Intermediate SSG   ≥ 25 & \< 50 (2/4)                  ≥ 0.4 & \< 0.8         ≥ 0.016 & \< 0.032     ≥ 0.6 & \< 1.2   ≥ 0.024 & \< 0.047
  Thick SSG          ≥ 50 & \< 75 (3/4)                  ≥ 0.8 & \< 1.2         ≥ 0.032 & \< 0.047     ≥ 1.2 & \< 1.8   ≥ 0.047 & \< 0.071

SSG, split-thickness skin graft.
